TY - JOUR AB - Since 2003, coronaviruses have caused multiple global pandemic diseases, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and coronavirus disease 2019 (COVID‑19). Clinical and autopsy findings suggest that the occurrence of kidney injury during infection may negatively affect the clinical outcomes of infected patients. The authoritative model predicts that outbreaks of other novel coronavirus pneumonias will continue to threaten human health in the future. The aim of the present systematic review was to summarize the basic knowledge of coronavirus, coronavirus infection‑associated kidney injury and the corresponding therapies, in order to provide new insights for clinicians to better understand the kidney involvement of coronavirus so that more effective therapeutic strategies can be employed against coronavirus infection in the future. AD - Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China The Graduate School of Fujian Medical University, Fuzhou, Fujian 350108, P.R. China Department of Radiology, The First Hospital of Changsha, Changsha, Hunan 410011, P.R. China AU - Feng,Zhicai AU - Chen,Yuqing AU - Wu,Yuqin AU - Wang,Jianwen AU - Zhang,Hao AU - Zhang,Wei DA - 2021/04/01 DO - 10.3892/etm.2021.9792 IS - 4 JO - Exp Ther Med KW - coronavirus kidney injury severe acute respiratory syndrome Middle East respiratory syndrome coronavirus disease 2019 PY - 2021 SN - 1792-0981 1792-1015 SP - 361 ST - Kidney involvement in coronavirus‑associated diseases (Review) T2 - Experimental and Therapeutic Medicine TI - Kidney involvement in coronavirus‑associated diseases (Review) UR - https://doi.org/10.3892/etm.2021.9792 VL - 21 ER -